493 related articles for article (PubMed ID: 15677396)
1. Glucocorticoid programming.
Seckl JR; Meaney MJ
Ann N Y Acad Sci; 2004 Dec; 1032():63-84. PubMed ID: 15677396
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.
Seckl JR; Holmes MC
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):479-88. PubMed ID: 17515892
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid "programming" and PTSD risk.
Seckl JR; Meaney MJ
Ann N Y Acad Sci; 2006 Jul; 1071():351-78. PubMed ID: 16891583
[TBL] [Abstract][Full Text] [Related]
4. Prenatal glucocorticoids and long-term programming.
Seckl JR
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U49-62. PubMed ID: 15554887
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
Seckl JR; Cleasby M; Nyirenda MJ
Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
[TBL] [Abstract][Full Text] [Related]
6. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming.
Cottrell EC; Holmes MC; Livingstone DE; Kenyon CJ; Seckl JR
FASEB J; 2012 May; 26(5):1866-74. PubMed ID: 22321728
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences.
O'Regan D; Welberg LL; Holmes MC; Seckl JR
Semin Neonatol; 2001 Aug; 6(4):319-29. PubMed ID: 11972433
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ
Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
Reynolds RM
Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
[TBL] [Abstract][Full Text] [Related]
10. Foetal and placental 11β-HSD2: a hub for developmental programming.
Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
[TBL] [Abstract][Full Text] [Related]
11. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11beta-hydroxysteroid dehydrogenase 1 and 2 in the fetal and postnatal ovine hippocampus: ontogeny and effects of prenatal glucocorticoid exposure.
Sloboda DM; Moss TJ; Li S; Matthews SG; Challis JR; Newnham JP
J Endocrinol; 2008 May; 197(2):213-20. PubMed ID: 18434351
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring.
Welberg LA; Seckl JR; Holmes MC
Eur J Neurosci; 2000 Mar; 12(3):1047-54. PubMed ID: 10762336
[TBL] [Abstract][Full Text] [Related]
14. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.
Jansson T; Powell TL
Clin Sci (Lond); 2007 Jul; 113(1):1-13. PubMed ID: 17536998
[TBL] [Abstract][Full Text] [Related]
15. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
[TBL] [Abstract][Full Text] [Related]
16. Nicotine-induced over-exposure to maternal glucocorticoid and activated glucocorticoid metabolism causes hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic alterations in fetal rats.
Xu D; Liang G; Yan YE; He WW; Liu YS; Chen LB; Magdalou J; Wang H
Toxicol Lett; 2012 Mar; 209(3):282-90. PubMed ID: 22265867
[TBL] [Abstract][Full Text] [Related]
17. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants.
Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Andersson S
Pediatr Res; 2006 Apr; 59(4 Pt 1):575-8. PubMed ID: 16549532
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development.
Yu P; Zhou J; Ge C; Fang M; Zhang Y; Wang H
Sci Total Environ; 2022 Jun; 827():154396. PubMed ID: 35259391
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health.
Meaney MJ; Szyf M; Seckl JR
Trends Mol Med; 2007 Jul; 13(7):269-77. PubMed ID: 17544850
[TBL] [Abstract][Full Text] [Related]
20. Cadmium exposure during pregnancy reduces birth weight and increases maternal and foetal glucocorticoids.
Ronco AM; Urrutia M; Montenegro M; Llanos MN
Toxicol Lett; 2009 Aug; 188(3):186-91. PubMed ID: 19379801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
